Research ethics and stem cells: Is it time to re-think current approaches to oversight?

EMBO Reports

Volumn 16, Issue 1, 2015, Pages 2-6

  Caulfield, Timothy ^a   Kamenova, Kalina ^a   Ogbogu, Ubaka ^a   Zarzeczny, Amy ^b   Baltz, Jay ^c   Benjaminy, Shelly ^d   Cassar, Paul A ^e   Clark, Marianne ^a   Isasi, Rosario ^f   Knoppers, Bartha ^f   Knowles, Lori ^a   Korbutt, Gregory ^g   Lavery, James V ^h   Lomax, Geoffrey P ⁱ   Master, Zubin ^j   McDonald, Michael ^d   Preto, Nina ^k   Toews, Maeghan ^a  

^a UNIVERSITY OF ALBERTA   (Canada)

^b UNIVERSITY OF REGINA   (Canada)

^c OTTAWA HOSPITAL RESEARCH INSTITUTE   (Canada)

^d UNIVERSITY OF BRITISH COLUMBIA   (Canada)

^e Stem Cell Network   (Canada)

^f MCGILL UNIVERSITY   (Canada)

^g UNIVERSITY OF ALBERTA   (Canada)

^h ST MICHAEL'S HOSPITAL   (Canada)

ⁱ California Institute for Regenerative Medicine   (United States)

^j ALBANY MEDICAL COLLEGE   (United States)

^k Engage Associates Consulting Group   (Canada)

more..

Author keywords

[No Author keywords available]

Indexed keywords

RADIOACTIVE MATERIAL; RECOMBINANT DNA;

ADVISORY COMMITTEE; ARTICLE; BETA THALASSEMIA; BLINDNESS; CELL LINE; CELL NUCLEUS TRANSPLANTATION; CHIMERA; CLINICAL RESEARCH; CLINICAL TRIAL (TOPIC); COMMODIFICATION; DEVELOPMENT; EMBRYO RESEARCH; EMBRYONIC STEM CELL; EMPIRICAL RESEARCH; ENGRAFTMENT; GENE THERAPY; GENE TRANSFER; GENETICS; GERM LINE; GOVERNMENT; HEALTH CARE POLICY; HEMOPHILIA; HUMAN; HUMAN EMBRYO; IMMUNE DEFICIENCY; INCIDENTAL FINDING; KNOWLEDGE BASE; MEDICAL RESEARCH; METHODOLOGY; MOLECULAR CLONING; NEOPLASM; NONHUMAN; OOCYTE; OOCYTE DONATION; PARKINSON DISEASE; PLURIPOTENT STEM CELL; PRACTICE GUIDELINE; PRIORITY JOURNAL; REPRODUCTION; RESEARCH ETHICS; RISK ASSESSMENT; RISK FACTOR; SOCIAL NORM; SOMATIC CELL; STEM CELL; STEM CELL LINE; STEM CELL RESEARCH; TERATOMA; CANADA; ETHICS; LEGISLATION AND JURISPRUDENCE; ORGANIZATION AND MANAGEMENT; UNITED STATES;

BIOMEDICAL RESEARCH; CANADA; EMBRYO RESEARCH; ETHICS, RESEARCH; HUMANS; STEM CELL RESEARCH; UNITED STATES;

EID: 84924989397     PISSN: 1469221X     EISSN: 14693178     Source Type: Journal    
DOI: 10.15252/embr.201439819     Document Type: Article

References (8)

1. Dolgin E, (2013) Time to ditch stand-alone stem cell oversight panels, experts say. Nat Med 19: 250
2. Zarzeczny A, Scott C, Hyun I, Bennett J, Chandler J, Charge S, Heine H, Isasi R, Kato K, Lovell-Badge R, et al, (2009) iPS cells: mapping the policy issues. Cell 139: 1032-1037
3. Greely HT, (2013) Assessing ESCROs: yesterday and tomorrow. Am J Bioeth 13: 44-52
4. Nisbet M, Markowitz EM, (2014) Understanding public opinion in debates over biomedical research: looking beyond political partisanship to focus on beliefs about science and society. PLoS ONE 9: 1-12
5. Caulfield T, Rachul C, Zarzeczny A, (2012) The evolution of policy issues in stem cell research: an international survey. Stem Cell Rev Rep 8: 1037-1042
6. Haimes E, Taylor K, Turkmendag I, (2012) Eggs, ethics and exploitation? Investigating women's experiences of an egg sharing scheme. Sociol Health Illn 34: 1199-1214
7. Robillard JM, Roskams-Edris D, Kuzeljevic B, Illes J, (2014) Prevailing public perceptions of the ethics of gene therapy. Hum Gene Ther 25: 1-7
8. Isasi R, Knoppers BM, Andrews PW, Bredenoord AL, Colman A, Hin LE, Hull SC, Kim O, Lomax G, Morris C, et al, (2012) The disclosure and management of research findings in stem cell research and banking: policy statement. Regen Med 7: 439-448